DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

State Key Laboratory of Pharmaceutical Biotechnology, HKU has the following research output in the current window (1 January 2025 - 31 December 2025) of the Nature Index. Click on Count to view a list ...

Chinese biotech firms are striking big global deals as drug makers, but could artificial intelligence take them to the next ...

According to market consultancy Frost & Sullivan, the global AI-enabled pharmaceutical R&D market is projected to grow from ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

F rom blockbuster drugs that garner media attention to smaller innovations that help millions maintain health, the biotech and pharmaceutical industries have an impact on everyone’s life. Meanwhile, ...

The threat of new tariffs on drugmakers has set off a debate within the biotech industry over whether to cut voluntary ...

First commercial agreement with a top 5 global pharmaceutical company anchors a growing pipeline of enterprise discussions; runway secured into late 2027GAITHERSBURG, Md., April 13, 2026 (GLOBE ...

Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied about 35% over the past six months (as of Nov. 20, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 12%). Year to ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced the appointment of John A. Orwin as Chair of its Board of Directors. Mr. Orwin ...

Add Yahoo as a preferred source to see more of our stories on Google. Two companies are partnering with each other to create sustainable proteins that don't require animals, potentially transforming ...